Cognitive-Behavioral Perspective and Cognitive-Behavioral Therapy for People With Chronic Pain: Distinctions, Outcomes, and Innovations

2012 ◽  
Vol 26 (2) ◽  
pp. 93-113 ◽  
Author(s):  
Michelle Skinner ◽  
Hilary D. Wilson ◽  
Dennis C. Turk

This article reviews the cognitive-behavioral (CB) perspective on chronic pain and discusses the distinction between this perspective and cognitive and behavioral techniques. We describe the general efficacy of cognitive-behavioral therapy (CBT) in the treatment of people with chronic pain along with some of the limitations of published outcome studies. We discuss advances in moderation and mediation of treatment outcomes. Lastly, we discuss the need for research that takes into account growing interest in evidence-based medicine, methods that address responders and nonresponders, individual trajectories, how we might advance and refine CBT, and strategies related to relapse prevention, maintenance, and adherence enhancement taking advantage of evolving technological methods of service delivery. We provide recommendations on how to approach studies of CBT efficacy as a function of better understanding of patient characteristics and context. We advocate for the potential of the CB perspective for all healthcare providers regardless of discipline or training.




2019 ◽  
Vol 194 ◽  
pp. 460-467 ◽  
Author(s):  
Declan T. Barry ◽  
Mark Beitel ◽  
Christopher J. Cutter ◽  
David A. Fiellin ◽  
Robert D. Kerns ◽  
...  


2018 ◽  
Vol 99 (11) ◽  
pp. e149
Author(s):  
Dawn Ehde ◽  
Jeanne Hoffman ◽  
Nancy Temkin ◽  
Rhonda Williams ◽  
Sureyya Dikmen ◽  
...  


2015 ◽  
Vol 3 (3) ◽  
pp. 63-69 ◽  
Author(s):  
Pirhossein Kolivand ◽  
Azadeh Nazari Mahin ◽  
Robabeh Jafari ◽  
◽  
◽  
...  


BJPsych Open ◽  
2021 ◽  
Vol 7 (S1) ◽  
pp. S164-S164
Author(s):  
Mohammed Binnwejim ◽  
Atheer Alhumade ◽  
Deiaaeldin Hosny ◽  
Mohamed Alhabib

AimsTo examine the therapeutic efficacy and effectiveness of cognitive behavior therapy and pharmacotherapy in the treatment of Major Captagon (Fenethylline) Dependence.MethodA 41 outpatients males selected for the study, diagnosed as they are suffering from Captagon Dependence according to the DSM-5, with mean age 34.58 ± 5.11. The sample was divided into three experimental groups, (A) (N = 14) treated by cognitive behavior therapy (CBT) and pharmacotherapy in combination. (B) (N = 13) treated by CBT alone. (C) (N = 14) treated by pharmacotherapy alone. All groups were assigned to four measurements, one for the baseline before any treatment interventions, one post-treatment evaluation and two for follow-up within a short and long time. Non-parametric statistics were used to analyze the data collected by SPSS.ResultThere is no significant intra-group differences were found in terms of baseline assessment. There was no significant discrepancy between the first and the second group except in the term of reducing Captagon craving, as it was clearer in the first group in comparison with other groups. There was a clear significant discrepancy between the first and third groups, for all the study variables and it is phases of assessment especially follow-up. There was a clear degree of differences among the second and the third group, through the different phases of post-assessment, which refers to the great efficacy and effectiveness of CBT in Treating Captagon Dependence CBT was proved to be more effective than pharmacotherapy in the treatment of Captagon Dependence. The combination of CBT and pharmacotherapy was more effective than each other alone in the treatment of Captagon Dependence and Relapse Prevention.ConclusionAvailable evidence suggests that cognitive–behavioral therapy is an effective intervention method for psychological aspects of automatic thoughts, depression, negative health beliefs, craving, and relapse prevention, although its efficacy in reducing Captagon (Fenethylline) dependence.





Sign in / Sign up

Export Citation Format

Share Document